| Balance Sheets | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Cash and cash equivalents | 2,445,500 | 2,938,000 | 2,685,600 | 3,272,800 |
| Short-term investments (note 5) | 1,226,000 | 1,288,300 | 1,156,400 | 789,400 |
| Accounts receivable, net of allowances of 15.6 and 15.0, respectively | 775,700 | 659,600 | 693,300 | 697,000 |
| Other receivables | 197,300 | 252,500 | 199,500 | 205,600 |
| Inventories (note 2) | 1,119,000 | 1,126,200 | 1,140,900 | 1,141,700 |
| Prepaid expenses | 135,700 | 135,000 | 125,200 | 110,000 |
| Other current assets | 329,500 | 339,300 | 323,400 | 314,400 |
| Current assets of discontinued operations (note 5) | NaN | 0 | 34,600 | 46,300 |
| Total current assets | 6,228,700 | 6,738,900 | 6,358,900 | 6,577,200 |
| Long-term investments (note 5) | 285,600 | 278,600 | 274,700 | 298,500 |
| Property, plant, and equipment, net | 1,823,100 | 1,811,900 | 1,743,300 | 1,726,600 |
| Operating lease right-of-use assets | 99,300 | 102,700 | 96,500 | 99,000 |
| Goodwill | 1,819,600 | 1,768,600 | 1,768,500 | 1,776,700 |
| Other intangible assets, net | 1,227,900 | 1,128,200 | 1,130,800 | 1,172,800 |
| Deferred income taxes | 1,098,100 | 1,138,100 | 1,099,900 | 1,082,100 |
| Other assets (note 2) | 738,900 | 730,200 | 784,800 | 743,000 |
| Non-current assets of discontinued operations (note 5) | NaN | 0 | 14,800 | 12,800 |
| Total assets | 13,321,200 | 13,697,200 | 13,272,200 | 13,488,700 |
| Accounts payable | 181,100 | 227,500 | 165,000 | 162,100 |
| Accrued and other liabilities (note 2) | 1,203,600 | 1,561,700 | 1,393,900 | 1,214,400 |
| Operating lease liabilities | 24,300 | 24,500 | 26,800 | 25,900 |
| Current liabilities of discontinued operations (note 5) | NaN | 0 | 2,300 | 2,300 |
| Total current liabilities | 1,409,000 | 1,813,700 | 1,588,000 | 1,404,700 |
| Long-term debt | 598,500 | 598,300 | 598,200 | 598,000 |
| Operating lease liabilities | 80,100 | 82,600 | 75,300 | 78,700 |
| Uncertain tax positions | 555,400 | 502,700 | 442,900 | 421,600 |
| Litigation settlement accrual | NaN | 0 | NaN | NaN |
| Other liabilities | 350,700 | 362,300 | 362,600 | 379,200 |
| Non-current liabilities of discontinued operations (note 4) | NaN | NaN | 200 | NaN |
| Total liabilities | 2,993,700 | 3,359,600 | 3,067,200 | 2,882,200 |
| Additional paid-in capital | 2,781,500 | NaN | NaN | NaN |
| Retained earnings | 14,621,200 | NaN | NaN | NaN |
| Accumulated other comprehensive loss (note 13) | -221,300 | NaN | NaN | NaN |
| Treasury stock, at cost, 83.0 and 78.0 shares, respectively | 7,513,900 | NaN | NaN | NaN |
| Total edwards lifesciences corporation stockholders' equity | 10,327,500 | 10,337,600 | 10,205,000 | 10,545,300 |
| Noncontrolling interest (note 9) | NaN | 0 | 0 | 61,200 |
| Total stockholders' equity | NaN | 10,337,600 | 10,205,000 | 10,606,500 |
| Total liabilities and equity | 13,321,200 | 13,697,200 | 13,272,200 | 13,488,700 |
Edwards Lifesciences Corp (EW)
Edwards Lifesciences Corp (EW)